Monoclonal Antibody to Tissue Factor Pathway Inhibitor (TFPI) Homo sapiens (Human) Monoclonal antibody

TFI; EPI; LACI; TFPI1; Lipoprotein-Associated Coagulation Inhibitor; Extrinsic pathway inhibitor

Add to Cart Distributors
Overview
Properties
  • SourceMonoclonal antibody preparation, Host Mouse
  • Ig Isotype IgG, Clone Number n/a
  • PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
  • LabelNone
  • Immunogen n/a
  • Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
  • TraitsLiquid, Concentration 1mg/mL
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Monoclonal Antibody to Tissue Factor Pathway Inhibitor (TFPI) Packages (Simulation)
  • Monoclonal Antibody to Tissue Factor Pathway Inhibitor (TFPI) Packages (Simulation)
  • MAA394Hu26.jpg Western Blot; Sample: Rat Plasma Primary Ab: 0.3µg/ml Mouse Anti-Human TFPI Antibody Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specifity

The antibody is a mouse monoclonal antibody raised against TFPI. It has been selected for its ability to recognize TFPI in immunohistochemical staining and western blotting.

Usage

Western blotting: 0.2-2µg/mL;1:500-5000
Immunohistochemistry: 5-20µg/mL;1:50-200
Immunocytochemistry: 5-20µg/mL;1:50-200
Optimal working dilutions must be determined by end user.

Storage

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Giveaways

Citations

  • Tissue factor pathway inhibitor in paediatric patients with nephrotic syndromeSajch: 383
  • Cathepsin G in Experimental Tuberculosis: Relevance for Antibacterial Protection and Potential for ImmunotherapyPubMed: 26320257
  • Trans‐fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll‐like receptorsPubMed: 25546502
  • Endothelial cell‐anchored tissue factor pathway inhibitor regulates tumor metastasis to the lung in micePubMed: 25945811
  • Extracellular vesicles from malignant effusions induce tumor cell migration: inhibitory effect ofLMWH tinzaparin.pubmed:27435911
  • Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansonipubmed:29128645

Recommend products